Asaf A. Qureshi

6.1k total citations
100 papers, 4.8k citations indexed

About

Asaf A. Qureshi is a scholar working on Molecular Biology, Biochemistry and Surgery. According to data from OpenAlex, Asaf A. Qureshi has authored 100 papers receiving a total of 4.8k indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Molecular Biology, 35 papers in Biochemistry and 29 papers in Surgery. Recurrent topics in Asaf A. Qureshi's work include Antioxidant Activity and Oxidative Stress (31 papers), Cholesterol and Lipid Metabolism (28 papers) and Plant biochemistry and biosynthesis (16 papers). Asaf A. Qureshi is often cited by papers focused on Antioxidant Activity and Oxidative Stress (31 papers), Cholesterol and Lipid Metabolism (28 papers) and Plant biochemistry and biosynthesis (16 papers). Asaf A. Qureshi collaborates with scholars based in United States, Pakistan and Malaysia. Asaf A. Qureshi's co-authors include Charles E. Elson, David M. Peterson, W. C. Burger, Nilofer Qureshi, Farooq Ahmad Khan, John W. Porter, Bradley C. Pearce, Huanbiao Mo, Christopher J. Papasian and David C. Morrison and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and American Journal of Clinical Nutrition.

In The Last Decade

Asaf A. Qureshi

100 papers receiving 4.4k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Asaf A. Qureshi 1.8k 1.6k 1.2k 750 732 100 4.8k
Charles E. Elson 2.4k 1.3× 1.0k 0.6× 725 0.6× 834 1.1× 751 1.0× 102 5.1k
Siegfried Wolffram 1.7k 0.9× 1.8k 1.1× 769 0.6× 285 0.4× 909 1.2× 113 5.8k
Lilian B.M. Tijburg 1.1k 0.6× 2.5k 1.6× 761 0.6× 386 0.5× 484 0.7× 53 5.1k
Tae‐Sook Jeong 3.0k 1.6× 1.4k 0.9× 446 0.4× 732 1.0× 1.3k 1.8× 191 6.6k
Monica Deiana 1.0k 0.6× 1.2k 0.7× 657 0.5× 498 0.7× 593 0.8× 96 3.6k
Kenneth K. Carroll 1.3k 0.7× 641 0.4× 1.1k 0.9× 343 0.5× 373 0.5× 88 3.8k
Michihiro Sugano 2.5k 1.4× 746 0.5× 3.6k 3.0× 2.3k 3.0× 904 1.2× 372 8.2k
Ikuo Ikeda 1.8k 1.0× 926 0.6× 2.2k 1.8× 2.0k 2.7× 262 0.4× 164 5.9k
Diane F. Birt 2.3k 1.3× 787 0.5× 1.1k 0.9× 378 0.5× 1.1k 1.4× 144 5.8k
Hirofumi Tachibana 2.4k 1.3× 1.4k 0.9× 881 0.7× 270 0.4× 421 0.6× 256 6.8k

Countries citing papers authored by Asaf A. Qureshi

Since Specialization
Citations

This map shows the geographic impact of Asaf A. Qureshi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Asaf A. Qureshi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Asaf A. Qureshi more than expected).

Fields of papers citing papers by Asaf A. Qureshi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Asaf A. Qureshi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Asaf A. Qureshi. The network helps show where Asaf A. Qureshi may publish in the future.

Co-authorship network of co-authors of Asaf A. Qureshi

This figure shows the co-authorship network connecting the top 25 collaborators of Asaf A. Qureshi. A scholar is included among the top collaborators of Asaf A. Qureshi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Asaf A. Qureshi. Asaf A. Qureshi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Qureshi, Nilofer, et al.. (2023). Dysregulation of Gene Expression of Key Signaling Mediators in PBMCs from People with Type 2 Diabetes Mellitus. International Journal of Molecular Sciences. 24(3). 2732–2732. 1 indexed citations
2.
3.
Qureshi, Asaf A., Xiaoyu Tan, Júlia Reis, et al.. (2011). Inhibition of nitric oxide in LPS-stimulated macrophages of young and senescent mice by δ-tocotrienol and quercetin. Lipids in Health and Disease. 10(1). 239–239. 57 indexed citations
4.
Reis, Júlia, Alexei F. Kisselev, Christopher J. Papasian, et al.. (2011). LPS-Induced Formation of Immunoproteasomes: TNF-α and Nitric Oxide Production are Regulated by Altered Composition of Proteasome-Active Sites. Cell Biochemistry and Biophysics. 60(1-2). 77–88. 58 indexed citations
5.
Hamid, Saeed, et al.. (2011). Gene profiling of early and advanced liver disease in chronic hepatitis C patients. Hepatology International. 5(3). 782–788. 9 indexed citations
6.
Qureshi, Asaf A., C W Karpen, Nilofer Qureshi, et al.. (2011). Tocotrienols-induced inhibition of platelet thrombus formation and platelet aggregation in stenosed canine coronary arteries. Lipids in Health and Disease. 10(1). 58–58. 24 indexed citations
7.
Qureshi, Asaf A., Júlia Reis, Christopher J. Papasian, David C. Morrison, & Nilofer Qureshi. (2010). Tocotrienols inhibit lipopolysaccharide-induced pro-inflammatory cytokines in macrophages of female mice. Lipids in Health and Disease. 9(1). 143–143. 58 indexed citations
8.
Qureshi, Nilofer, Stefanie N. Vogel, Charles W. Van Way, et al.. (2005). The Proteasome: A Central Regulator of Inflammation and Macrophage Function. Immunologic Research. 31(3). 243–260. 82 indexed citations
9.
Qureshi, Asaf A., et al.. (2002). Dose-dependent suppression of serum cholesterol by tocotrienol-rich fraction (TRF25) of rice bran in hypercholesterolemic humans. Atherosclerosis. 161(1). 199–207. 212 indexed citations
10.
Qureshi, Asaf A., et al.. (2002). Effects of stabilized rice bran, its soluble and fiber fractions on blood glucose levels and serum lipid parameters in humans with diabetes mellitus Types I and II. The Journal of Nutritional Biochemistry. 13(3). 175–187. 129 indexed citations
11.
Qureshi, Asaf A., et al.. (2001). Novel Tocotrienols of Rice Bran Inhibit Atherosclerotic Lesions in C57BL/6 ApoE-Deficient Mice. Journal of Nutrition. 131(10). 2606–2618. 68 indexed citations
12.
Qureshi, Asaf A., et al.. (2001). Synergistic effect of tocotrienol-rich fraction (TRF25) of rice bran and lovastatin on lipid parameters in hypercholesterolemic humans. The Journal of Nutritional Biochemistry. 12(6). 318–329. 75 indexed citations
13.
Qureshi, Asaf A. & David M. Peterson. (2001). The combined effects of novel tocotrienols and lovastatin on lipid metabolism in chickens. Atherosclerosis. 156(1). 39–47. 30 indexed citations
14.
He, Lei, et al.. (1997). Isoprenoids Suppress the Growth of Murine B16 Melanomas In Vitro and In Vivo. Journal of Nutrition. 127(5). 668–674. 233 indexed citations
15.
Qureshi, Asaf A., et al.. (1996). Dietary α-Tocopherol Attenuates the Impact of γ-Tocotrienol on Hepatic 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Activity in Chickens. Journal of Nutrition. 126(2). 389–394. 133 indexed citations
16.
Pearce, Bradley C., Richard Parker, Douglas D. Dischino, et al.. (1994). Inhibitors of Cholesterol Biosynthesis. 2. Hypocholesterolemic and Antioxidant Activities of Benzopyran and Tetrahydronaphthalene Analogs of the Tocotrienols. Journal of Medicinal Chemistry. 37(4). 526–541. 111 indexed citations
17.
Pearce, Bradley C., et al.. (1992). Hypocholesterolemic activity of synthetic and natural tocotrienols.. Journal of Medicinal Chemistry. 35(20). 3595–3606. 216 indexed citations
18.
Qureshi, Asaf A., N Qureshi, J. J. Wright, et al.. (1991). Lowering of serum cholesterol in hypercholesterolemic humans by tocotrienols (palmvitee). American Journal of Clinical Nutrition. 53(4). 1021S–1026S. 225 indexed citations
19.
20.
Kamal, Adeela, et al.. (1971). Studies in the biochemistry of microorganisms part 24 structure and stereochemistry of taji xanthone a metabolic product of aspergillus stellatus. Pakistan journal of scientific and industrial research. 14. 90–103. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Charles E. Elson Breakdown of academic impact, for papers by Siegfried Wolffram Breakdown of academic impact, for papers by Lilian B.M. Tijburg Breakdown of academic impact, for papers by Tae‐Sook Jeong Breakdown of academic impact, for papers by Monica Deiana Breakdown of academic impact, for papers by Kenneth K. Carroll Breakdown of academic impact, for papers by Michihiro Sugano Breakdown of academic impact, for papers by Ikuo Ikeda Breakdown of academic impact, for papers by Diane F. Birt Breakdown of academic impact, for papers by Hirofumi Tachibana
Rankless by CCL
2026